Showing results (61-70 of 579) with videos related to
Sort By:
Pageof 58
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 22, 2001
[Granulomatous slack skin: partial remission following intralesional administration of interferon-alpha and PUVA]T Schmook, G Hofbauer, W Kempf, et al.Dermatology (Basel, Switzerland)|June 9, 2005
Atypical poorly differentiated cutaneous T-cell lymphoma with an angiocentric growth pattern presenting histologically as vasculitisB Laetsch, G Hofbauer, W Kempf, et al.Archives of Dermatology|April 1, 1993
Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulationR Dummer, O Kohl, J Gillessen, et al.Journal of the American Academy of Dermatology|September 1, 1996
MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanomaR Böni, A Doguoglu, G Burg, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 1990
[Interleukin 2: immunologic background and clinical use in tumor therapy]R Dummer, H Welters, U Keilholz, et al.Onkologie|September 7, 2004
The spectrum of mesenchymal skin neoplasms reflected by the new WHO classificationM Beyeler, W Kempf, J Hafner, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 1, 1996
Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chainsR Dummer, G Posseckert, K Sugamura, et al.Archives of Dermatology|September 18, 1999
Pityriasis rosea is not associated with human herpesvirus 7W Kempf, V Adams, M Kleinhans, et al.Dermatology (Basel, Switzerland)|September 11, 2001
Swiss guidelines for the treatment and follow-up of cutaneous melanomaR Dummer, U Bösch, R Panizzon, et al.Archives of Dermatology|March 21, 2000
Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphomaL Heinzerling, R Dummer, W Kempf, et al.Pageof 58